---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-012238"
form_type: "8-K"
ticker: "MYO"
cik: "0001369290"
company_name: "MYOMO, INC."
filed_at: "2023-04-10T23:59:59+00:00"
generated_at: "2026-06-17T04:02:26.551275+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Myomo receives $1.7M final license fee from China JV, enabling MyoPro manufacturing and sales in China

## Summary
- Received final $1.7M of initial license fee from Jiangxi Myomo JV; total upfront fee now $2.7M.
- Enables start of technology transfer to JV for MyoPro manufacture and sale in China, Hong Kong, Taiwan, Macau.
- JV committed to purchase at least $10.75M in MyoPro Control System Units over 10 years, subject to regulatory approvals.
- Myomo owns 19.9% of JV; majority partner is Anhui Ryzur Medical Equipment Manufacturing.
- Payment will be recognized as license revenue in Q2 2023.

## SEC filing metadata
- accession: 0000950170-23-012238
- form_type: 8-K
- ticker: MYO
- cik: 0001369290
- company_name: MYOMO, INC.
- filed_at: 2023-04-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369290/000095017023012238/0000950170-23-012238-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369290/000095017023012238/myo-20230406.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-012238
- JSON: https://secwatch.observer/filing/0000950170-23-012238.json
- Plain text: https://secwatch.observer/filing/0000950170-23-012238.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.